Small Intestine Cancer

Small Intestine Cancer, explained simply

Everything a patient or caregiver wants to understand: what small intestine cancer is, how doctors describe its stage, the standard treatment plan, how radiation works, and the research shaping care today.

On this page

Watch: the CureRays® explainer series

Watch Dr. Hess explain radiation therapyPlain-language videos on how radiation works, what treatment feels like, and what to expect — on the CureRays® YouTube channel.

Prefer to read? The full guide below is complete on its own, with tables you can revisit any time.

What is small intestine cancer?

Small intestine cancer is an uncommon cancer that begins in the small bowel — the long, coiled tube between the stomach and the colon where most of the body's food is digested and absorbed. Even though the small intestine makes up most of the length of the digestive tract, cancer there is rare compared with the stomach or colon, partly because food moves through it quickly and its lining renews itself often. Several different cancers can arise here, and they behave differently from one another, so identifying the exact type is an important first step. Because symptoms — like belly pain, cramping, anemia, or a blockage — can be vague and come on slowly, small intestine cancer is sometimes found later than other gut cancers. Treatment is tailored to the specific type, with surgery as the backbone for cancers that can be removed.

In one line: Small intestine cancer is an uncommon tumor of the long middle section of the gut; surgery is the main treatment, with chemotherapy and focused radiation in supporting roles.

The main types

Doctors group small intestine cancer by where it starts and how it behaves:

TypeWhat it means, simply
AdenocarcinomaThe classic 'small bowel cancer' that starts in the lining, similar to colon cancer; most common in the first part of the small intestine (the duodenum).
Neuroendocrine tumor (carcinoid)A slow-growing tumor of hormone-making cells, often in the lower small bowel; covered in more depth in our neuroendocrine tumor guide.
LymphomaA cancer of immune cells that can form in the small intestine's lining tissue; treated mainly with medicine rather than surgery.
Sarcoma / GISTTumors arising from the muscle or supporting cells of the bowel wall, including gastrointestinal stromal tumors (GIST), which have their own guide.

Staging, in plain terms

For the most common type, adenocarcinoma, doctors use the TNM system: how deep the Tumor has grown through the bowel wall, whether nearby lymph Nodes contain cancer, and whether it has spread (Metastasized) to distant organs such as the liver. Other types — like neuroendocrine tumors or lymphoma — use their own staging systems. Knowing the exact type and stage tells the team whether surgery alone is enough or whether added treatment is needed.

TNM (type-dependent)What it generally means
Stage 1An early cancer limited to the inner layers of the bowel wall, without lymph node or distant spread — usually removed by surgery.
Stage 2The cancer has grown more deeply into or through the bowel wall but has not reached lymph nodes.
Stage 3Cancer has spread to nearby lymph nodes but not to distant organs; surgery is often followed by chemotherapy.
Stage 4The cancer has spread to distant organs such as the liver or the lining of the abdomen; treated mainly with medicine, with surgery or radiation to relieve specific problems.
Plain-language takeaway: Staging tells your team how much disease there is and where — but your tumor's biology matters too. Two people described the same way can still have different plans, and that's a good thing.

The standard of care

Small Intestine Cancer is almost always treated by a team that may include a surgeon, a medical oncologist, and a radiation oncologist, combining therapies for the best result. The usual building blocks are:

Surgery

Removing the affected segment of bowel along with nearby lymph nodes is the main treatment and the best chance for cure when the cancer can be taken out. The healthy ends are then rejoined.

Chemotherapy

Drug treatment is used after surgery for higher-risk cancers to lower the chance of return, and as the main treatment when the cancer has spread.

Targeted therapy and immunotherapy

For certain tumors with specific genetic features, newer medicines that target the cancer's vulnerabilities or harness the immune system can be options, especially in advanced disease.

Radiation therapy (selective)

Focused radiation has a supporting role — to treat cancer of the duodenum that is hard to remove, to relieve symptoms like bleeding or pain, or to control a specific deposit.

How radiation treatment works

Radiation uses focused high-energy x-rays to damage the DNA inside tumor cells so they can no longer grow and divide. The small intestine itself is sensitive to radiation and is always moving, so it has historically not been the main treatment for small bowel cancer. But modern, image-guided techniques make it possible to concentrate a precise dose on a fixed target — such as a tumor in the duodenum or a deposit in the liver — while protecting the rest of the gut. In small intestine cancer, radiation is used selectively: to help treat tumors that are hard to remove, to relieve bleeding, pain, or blockage, and to control specific spots that have spread. Treatments are painless and brief, given over a small number of sessions. Side effects depend on the area treated and are usually temporary, such as fatigue, nausea, or loose stools. Radiation works best here as a precise, supportive tool alongside surgery and medicine.

The main ways radiation is delivered for small intestine cancer:

Targeted external-beam radiation

Precise radiation, sometimes combined with chemotherapy, can treat tumors in the duodenum that are difficult to remove surgically, or shrink them before an operation.

Palliative radiation

Focused radiation aimed at a bleeding or obstructing tumor, or a painful deposit, to relieve symptoms and improve comfort when surgery isn't the right option.

Stereotactic body radiation (SBRT)

Highly precise, high-dose radiation in a few sessions can control a limited number of metastatic spots, such as in the liver, while sparing the surrounding bowel.

Latest studies shaping care

Care keeps improving — often toward getting the same excellent results with less burden on patients. A few developments:

Chemotherapy after surgery for higher-risk disease: Research supports adding chemotherapy after surgery for node-positive small bowel adenocarcinoma to lower the chance of the cancer returning, mirroring the approach used in colon cancer.[1]

BALLAD international trial and NCCN guidelines

Genetic testing opens new options: Testing tumors for features such as mismatch-repair deficiency can identify patients who benefit from immunotherapy, even in advanced small intestine cancer.[2]

KEYNOTE immunotherapy studies, Journal of Clinical Oncology

Better recognition and earlier diagnosis: Improved imaging and capsule endoscopy are helping doctors find small bowel tumors earlier, when surgery is more likely to be curative.[3]

Gastrointestinal endoscopy reviews

Common questions

Why is small intestine cancer so uncommon? The small intestine makes up most of the digestive tract's length, yet cancer there is rare. Doctors believe this is partly because food passes through quickly, the lining renews itself frequently, and the contents are more liquid and less irritating than in the colon.

Is small intestine cancer the same as colon cancer? Not exactly. The most common type, adenocarcinoma, is similar to colon cancer and treated in comparable ways, but the small intestine can also develop other cancers — neuroendocrine tumors, lymphoma, and GIST — each with its own treatment. Identifying the exact type guides care.

Will I need radiation? Often not. Surgery and, when needed, chemotherapy are the mainstays. Radiation is used selectively — for example, to treat a duodenal tumor that's hard to remove, to relieve bleeding or pain, or to control a deposit that has spread. Your team will tell you whether it fits your case.

References

Numbered sources for the studies cited above. Links open the primary publication on PubMed or the publisher’s site.

  1. BALLAD international trial and NCCN guidelines (no indexed identifier — see your care team)
  2. KEYNOTE immunotherapy studies, Journal of Clinical Oncology (no indexed identifier — see your care team)
  3. Gastrointestinal endoscopy reviews (no indexed identifier — see your care team)
Medical disclaimer: This guide is general patient education, not medical advice, and reflects widely accepted standards as of 2026. Your situation is unique — always discuss your diagnosis and options with your own care team. CureRays clinicians are here to help you understand your choices.

Talk to a CureRays radiation oncologist Back to all guides